PA
MNTA

Profund Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Profund Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,837
Closed -$327K – 1019
2020
Q2 		$327K Buy
+9,837
New +$313K 0.02% 548
2020
Q1 		– Sell
-11,375
Closed -$224K – 1239
2019
Q4 		$224K Sell
11,375
-429
-4% -$6.86K 0.01% 1107
2019
Q3 		$153K Buy
+11,804
New +$143K 0.01% 1212
2019
Q1 		– Sell
-11,564
Closed -$128K – 1258
2018
Q4 		$128K Sell
11,564
-3,527
-23% -$49.1K 0.01% 1081
2018
Q3 		$397K Sell
15,091
-2,121
-12% -$57.3K 0.02% 983
2018
Q2 		$352K Buy
17,212
+1,729
+11% +$37.1K 0.01% 1037
2018
Q1 		$281K Buy
15,483
+3,853
+33% +$64.2K 0.01% 1194
2017
Q4 		$162K Buy
+11,630
New +$157K 0.01% 1402
2017
Q3 		– Sell
-13,172
Closed -$223K – 1480
2017
Q2 		$223K Buy
13,172
+1,530
+13% +$23.3K 0.01% 1292
2017
Q1 		$155K Sell
11,642
-746
-6% -$11.7K 0.01% 1408
2016
Q4 		$186K Buy
12,388
+2,020
+19% +$26.7K 0.01% 1479
2016
Q3 		$121K Buy
+10,368
New +$122K 0.01% 1393
2016
Q1 		– Sell
-11,678
Closed -$173K – 1497
2015
Q4 		$173K Buy
+11,678
New +$195K 0.01% 1222
2015
Q3 		– Sell
-11,452
Closed -$261K – 1412
2015
Q2 		$261K Sell
11,452
-333
-3% -$6.63K 0.01% 1214
2015
Q1 		$179K Buy
+11,785
New +$153K 0.01% 1444
2014
Q3 		– Sell
-10,811
Closed -$131K – 1486
2014
Q2 		$131K Sell
10,811
-910
-8% -$10.7K 0.01% 1476
2014
Q1 		$137K Sell
11,721
-10,128
-46% -$172K 0.01% 1494
2013
Q4 		$386K Buy
21,849
+9,939
+83% +$167K 0.02% 1214
2013
Q3 		$171K Buy
+11,910
New +$182K 0.01% 1560

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Profund Advisors's MNTA Position: Q3 2020 in Review

Profund Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 9,837 shares — an estimated $327K sold.

Profund Advisors first reported a position in MNTA in Q3 2013 and held it in 19 quarters. The position peaked at $397K in Q3 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Profund Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Profund Advisors sold 9,837 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $327K.
  • Profund Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 19 quarters.
  • Profund Advisors's Momenta Pharmaceuticals, Inc. position peaked at $397K in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Profund Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.